Heterogeneity in efficacy of rolofylline using a risk-based evaluation in patients hospoitalized with acute heart failure
| Autor: | Marco Metra, Douwe Postmus, Beth Davison, Hans L. Hillege, Daniel Bloomfield, Piotr Ponikowski, John Teerlink, Michael Givertz, Gad Cotter, John Cleland, Howard Dittrich, Biniyam G. Demissei, Adriaan A. Voors, Licette C. Y. Liu, Christopher M. O'Connor |
|---|---|
| Přispěvatelé: | Methods in Medicines evaluation & Outcomes research (M2O), Cardiovascular Centre (CVC), Life Course Epidemiology (LCE), Groningen Kidney Center (GKC), Value, Affordability and Sustainability (VALUE) |
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Response to therapy business.industry medicine.disease Rolofylline Pathophysiology Natural history chemistry.chemical_compound chemistry Heart failure Internal medicine medicine Cardiology Etiology In patient Presentation (obstetrics) Cardiology and Cardiovascular Medicine Intensive care medicine business |
| Zdroj: | Journal of the American College of Cardiology, 67(13), 1440-1440. ELSEVIER SCIENCE INC |
| ISSN: | 0735-1097 |
| Popis: | There is substantial variation in the etiology, clinical presentation and pathophysiology of patients hospitalized for acute heart failure (AHF) that may influence their natural history and response to therapy. We performed a post-hoc analysis of the PROTECT trial that compared rolofylline, a |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|